|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM183765141 |
003 |
DE-627 |
005 |
20250209204302.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2008 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2008.08.010
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0613.xml
|
035 |
|
|
|a (DE-627)NLM183765141
|
035 |
|
|
|a (NLM)18930441
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Saresella, Marina
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 04.12.2008
|
500 |
|
|
|a Date Revised 13.11.2018
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a A dynamic equilibrium between proliferation and programmed cell death (PCD) of auto-reactive T lymphocytes plays a pivotal role in the prevention of autoimmune diseases. We analyzed T lymphocytes myelin basic protein (MBP)-specific PCD and proliferation in demyelinating diseases. Results showed that MBP-specific PCD was significantly decreased in CD4+ and CD8+ T lymphocytes of progressive multifocal leukoencephalopathy (PML), not determined leukoencephalopathy (NDLE), and acute MS (AMS) patients compared to patients with stable MS (SMS) and healthy controls. MBP-specific proliferation/PCD rates were high in CD4+ T lymphocytes of PML, NDLE, and AMS patients, and in CD8+ T cells of PML and AMS individuals alone. Alterations of the balance between MBP-specific proliferation and PCD are present in demyelinating diseases and could play a major role in the pathogenesis of these diseases
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a DNA, Viral
|2 NLM
|
650 |
|
7 |
|a Myelin Basic Protein
|2 NLM
|
650 |
|
7 |
|a Peptide Fragments
|2 NLM
|
700 |
1 |
|
|a Marventano, Ivana
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Guerini, Franca Rosa
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zanzottera, Milena
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Delbue, Serena
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Marchioni, Enrico
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Maserati, Renato
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Longhi, Renato
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ferrante, Pasquale
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Clerici, Mario
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 129(2008), 3 vom: 15. Dez., Seite 509-17
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:129
|g year:2008
|g number:3
|g day:15
|g month:12
|g pages:509-17
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.08.010
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 129
|j 2008
|e 3
|b 15
|c 12
|h 509-17
|